Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al

Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) Vol. 28; no. 10; pp. 666 - 667
Main Authors: James, N.D, Sydes, M.R, Clarke, N.W, Ritchie, A.W.S, Parmar, M.K.B
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2016
Subjects:
Antineoplastic Combined Chemotherapy Protocols
Hematology, Oncology and Palliative Medicine
Humans
Male
Neutropenia
Prostatic Neoplasms
Radiology
Taxoids
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0936-6555
1433-2981
DOI:10.1016/j.clon.2016.07.004